Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy.
Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuåsen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Børresen-Dale AL, Kristensen V, Edvardsen H. Halvorsen AR, et al. Among authors: touleimat n. Int J Cancer. 2014 Nov 1;135(9):2085-95. doi: 10.1002/ijc.28862. Epub 2014 Apr 5. Int J Cancer. 2014. PMID: 24658971 Free PMC article.
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.
Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J, Christensen BC, Kristensen VN. Fleischer T, et al. Among authors: touleimat n. Genome Biol. 2014;15(8):435. doi: 10.1186/PREACCEPT-2333349012841587. Epub 2014 Aug 22. Genome Biol. 2014. PMID: 25146004 Free PMC article.
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors.
Klajic J, Busato F, Edvardsen H, Touleimat N, Fleischer T, Bukholm I, Børresen-Dale AL, Lønning PE, Tost J, Kristensen VN. Klajic J, et al. Among authors: touleimat n. Clin Cancer Res. 2014 Dec 15;20(24):6357-66. doi: 10.1158/1078-0432.CCR-14-0297. Epub 2014 Oct 7. Clin Cancer Res. 2014. PMID: 25294903
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.
Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN. Fleischer T, et al. Among authors: touleimat n. Oncotarget. 2017 Jan 3;8(1):1074-1082. doi: 10.18632/oncotarget.13718. Oncotarget. 2017. PMID: 27911866 Free PMC article.
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors.
Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perälä M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG, Lingjærde OC, Sahlberg KK, Kristensen VN. Aure MR, et al. Among authors: touleimat n. Genome Biol. 2013 Nov 20;14(11):R126. doi: 10.1186/gb-2013-14-11-r126. Genome Biol. 2013. PMID: 24257477 Free PMC article.
MeQA: a pipeline for MeDIP-seq data quality assessment and analysis.
Huang J, Renault V, Sengenès J, Touleimat N, Michel S, Lathrop M, Tost J. Huang J, et al. Among authors: touleimat n. Bioinformatics. 2012 Feb 15;28(4):587-8. doi: 10.1093/bioinformatics/btr699. Epub 2011 Dec 22. Bioinformatics. 2012. PMID: 22199384
13 results